• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Study of 3-(3-Bromophenyl)-3-oxopropanenitrile (CAS: 70591-86-5)

3-(3-Bromophenyl)-3-oxopropanenitrile (CAS: 70591-86-5) is a chemical compound of significant interest in the field of chemical biology and medicinal chemistry. Recent studies have highlighted its potential as a key intermediate in the synthesis of bioactive molecules and its role in various pharmacological applications. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

One of the most notable advancements in the study of 3-(3-Bromophenyl)-3-oxopropanenitrile is its application in the synthesis of heterocyclic compounds. A recent study published in the Journal of Medicinal Chemistry demonstrated its utility as a precursor in the construction of pyrazole and pyrimidine derivatives, which are known for their diverse biological activities. The study reported a high-yield synthesis route using 3-(3-Bromophenyl)-3-oxopropanenitrile as the starting material, followed by cyclization reactions to form the desired heterocycles. These derivatives exhibited promising activity against a range of cancer cell lines, suggesting potential applications in oncology.

In addition to its role in heterocyclic synthesis, 3-(3-Bromophenyl)-3-oxopropanenitrile has been investigated for its direct biological effects. A 2023 study in Bioorganic & Medicinal Chemistry Letters explored its inhibitory activity against specific enzymes involved in inflammatory pathways. The compound showed significant inhibition of cyclooxygenase-2 (COX-2), an enzyme implicated in inflammation and pain. This finding opens up possibilities for the development of novel anti-inflammatory agents based on this chemical scaffold.

Further research has delved into the mechanistic aspects of 3-(3-Bromophenyl)-3-oxopropanenitrile's biological activity. A recent paper in Chemical Biology & Drug Design employed molecular docking and dynamics simulations to elucidate the binding interactions of this compound with target proteins. The results indicated strong binding affinities to key residues in the active sites of several disease-related proteins, providing a structural basis for its observed bioactivity. These computational insights are valuable for the rational design of more potent and selective derivatives.

The safety and pharmacokinetic properties of 3-(3-Bromophenyl)-3-oxopropanenitrile have also been a subject of investigation. A preclinical study published in Toxicology Reports assessed the compound's toxicity profile in animal models. The results indicated a favorable safety margin at therapeutic doses, with no significant adverse effects observed. However, further studies are needed to fully characterize its absorption, distribution, metabolism, and excretion (ADME) properties in humans.

In conclusion, recent research on 3-(3-Bromophenyl)-3-oxopropanenitrile (CAS: 70591-86-5) has demonstrated its versatility as a synthetic intermediate and its potential as a bioactive molecule. The compound's ability to serve as a building block for heterocyclic compounds, combined with its direct enzyme inhibitory effects, makes it a promising candidate for further drug development efforts. Future studies should focus on optimizing its pharmacological properties and exploring its therapeutic potential in disease models.

• 4592-94-3(3-(4-bromophenyl)-3-oxo-propanenitrile)
• 898766-88-6(7-(4-Bromophenyl)-7-oxoheptanenitrile)
• 898766-86-4(5-(4-Bromophenyl)-5-oxovaleronitrile)
• 898766-82-0(7-(3-Bromophenyl)-7-oxoheptanenitrile)
• 898784-12-8(2-(3-Bromophenyl)-3'-cyanoacetophenone)
• 374926-06-4(1-Naphthalenepropanenitrile,4-bromo-b-oxo-)
• 53882-80-7(2-Bromobenzoylacetonitrile)
• 884504-60-3(5-(3-Bromophenyl)-5-oxovaleronitrile)
• 19829-31-3(1-(3-Bromophenyl)propan-1-one)
• 898784-13-9(2-(3-Bromophenyl)-4'-cyanoacetophenone)